Too tired to mow the lawn? The kids are happily occupied? A nice breakfast is keeping you on the couch? Try these….And take the Michael Moore poll in the post below this one.

Leiner Health Products which makes store-brand vitamins and nutritional supplements, is also the second-largest supplier of OTC meds to supermarkets, pharmacies and mass merchants. Now, its laying off 540 workers while sweating out a reply from the FDA over manufacturing issues, The Herald of South Carolina reports. Big customers include Wal-Mart, Sam’s Club and CostCo.

Here’s a story indicating The New York Times, which has mostly beat up drugmakers in print lately, can still do a good piece about research. This one profiles Wyeth’s efforts to find Alzheimer’s treatments and, in the process, humanizes ceo Bob Essner.

A migraine drug that Merck is developing excites a researcher, whose migraine center has received funding from the drugmaker. But experts express skepticism about the drug’s prospects to The Star-Ledger of New Jersey.

At ASCO last week, Genentech appeared more like a vulnerable veteran being targeted by cocky rookies. The San Francisco Chronicle writes that the biotech’s product development chief is unfailingly confident that challenges lay in store for competitors and that the competition is “good for patients.”